32.2 C
Vientiane
Friday, May 16, 2025
spot_img
Home Blog Page 914

VIVOTEK’s “Safety Map” Expands to Eastern Taiwan, Boosting Community Safety with AI

TAIPEI, Jan. 13, 2025 /PRNewswire/ — In 2024, Hualien, Taiwan experienced devastating earthquakes and typhoons, necessitating rebuilding efforts and tourism revitalization. VIVOTEK (3454-TW), the global leading security solution provider, has stepped in to support the local economy by organizing the 4th “Safety Map” sustainability event. This year, the event was held in the historically significant Dachen New Village in Hualien, home to over 400 households. With 2025 marking the 75th anniversary of the migration of Dachen Island residents from Zhejiang, China, to Taiwan, the area is promoting tourism despite challenges like an aging population and increasing environmental risks.

VIVOTEK held the Sustainability Event-Safety Map in Dachen New Village, Hualien, to identify safety issues and provide solutions.
VIVOTEK held the Sustainability Event-Safety Map in Dachen New Village, Hualien, to identify safety issues and provide solutions.

VIVOTEK’s team devised diverse solutions to address safety concerns, aiming to combine smart security with local revitalization efforts. Their goal is to transform Dachen New Village, the largest settlement of Dachen residents in Taiwan, into a model safe-tourism destination that attracts visitors to experience its unique culture.

Caring as the Core: Expanding Social Impact Through a “Safety Map”

“VIVOTEK is dedicated to becoming the most trusted security brand in society. We aim to use our expertise to improve safety and forge a unique path of corporate sustainability. Now in its fourth year, the scale of our ‘Safety Map’ initiative continues to grow. This time, our work in Dachen New Village benefits over 1,500 residents and ensures that visiting tourists can explore without safety concerns. Additionally, having our team directly observe and address safety issues helps refine our product design to meet users’ needs better.” stated Alex Liao, VIVOTEK’s President.

Local Revitalization and Tourism: Boosting the Tourism Economy Through Immersive Experiences

The VIVOTEK security team also had an immersive theatrical experience created by Lamb Social Innovation Studio that delved into Dachen’s history. By understanding the area’s unique needs, they developed tailored safety solutions. “VIVOTEK incorporates “concern for others’ cares” as a core value in our sustainability efforts. Over the years, our ‘Safety Map’ events have spanned neighborhoods, mental retardation training institution and school, fostering a friendlier environment and expanding social impact. After the natural disasters that recently struck Hualien, leaving behind numerous safety hazards and declining tourist numbers, we hope to use our security expertise to collaborate with residents in enhancing safety and revitalizing Hualien’s tourism industry for a win-win outcome.” said Allen Hsieh, VIVOTEK’s Spokesperson and Director of the Global Marketing Division.

“This is the first in-depth collaboration between Dachen New Village and a corporation. The VIVOTEK security team genuinely considered the needs of the community’s residents. The event was a co-creation process where everyone brainstormed together, raising safety awareness among residents and inspiring optimism for the community’s future transformation.” said Chao Hsiao-Yen, Social Innovation lamb studio founder.

Customized Security Solutions with AI Technology: Building a Safer Dachen New Village

VIVOTEK’s security team, in collaboration with the local revitalization group Social Innovation lamb studio, worked with residents and elders to identify areas where safety could be enhanced. At the iconic tourist hotspot Ruan Bi Zhenjun Temple, the team explored ways to protect temple assets and visitor donations better while enhancing the environmental friendliness, allowing elderly or mobility-impaired individuals to enter and exit freely.

In the local park, they aimed to reduce disturbances caused by stray animals, improving the overall environment for residents. In the narrow alleys that showcase the history of Dachen’s settlers, the goal was to preserve the nostalgic charm of the village while optimizing the environment to make landmarks more recognizable for visitors. For family members living away from home, the community explored innovative technological solutions to enable remote monitoring of loved ones, strengthening familial bonds and care.

To address these challenges, VIVOTEK proposed a variety of security solutions. They included installing accessible spaces at the temple to accommodate visitors with mobility challenges, implementing smart lighting systems to enhance nighttime safety and utilizing AI cameras for real-time image analysis and stranger identification. The team also designed shared activity spaces to promote intergenerational interactions between the youth and seniors, fostering a sense of community. Emphasizing the importance of safety education, the team worked to raise awareness among residents.

Additionally, the project incorporated cutting-edge generative AI tools from the Taiwan Design Research Institute, which visualized proposed solutions quickly and effectively. This approach made it easier for residents to understand and implement the ideas, with the goal of transforming Dachen New Village into a safer, more livable community, fully prepared to welcome tourists.

DASI, LLC appoints new President as it continues to drive growth and strengthen leadership in the Aviation Aftermarket

Industry veteran Mike Heaton takes the helm to accelerate innovation and further enhance DASI, LLC’s market position

MIAMI, Jan. 13, 2025 /PRNewswire/ — DASI, LLC, a premier provider of aircraft inventory solutions, is pleased to announce the appointment of Mike Heaton as President of the company. Mike joins DASI from Satair, where he was Managing Director, Americas, overseeing business in the region covering four sites. With Mike’s extensive leadership experience and proven track record of success, this appointment comes as part of DASI’s ongoing efforts to scale operations to meet the growing demands of the market.

Rhod Gibson, the current president of DASI, LLC, will transition to the role of co-CEO, maintaining his vital role in the company’s leadership and future growth strategies.

DASI has achieved a compound annual growth rate of 25% since 2020, driven by unprecedented advancement in its core surplus parts solutions, continued acquisition of OEM and distributor channel partnerships and expansion into engine sales and leasing. As the company continues to experience significant growth, Mike will play a critical role in steering the organization toward new heights of innovation, operational excellence, and customer satisfaction. He will be responsible for overseeing day-to-day operations, leading the company’s expansion initiatives, and driving strategic decisions that will position DASI for sustainable long-term success.

“We are thrilled to welcome Mike Heaton to the leadership team,” said John Dziuba, co-CEO and Founder of DASI. “His proven ability to lead dynamic teams, optimize business performance, and champion growth initiatives aligns perfectly with our vision for the future. As we scale to meet new opportunities, Mike will be instrumental in ensuring we remain agile and forward-thinking.”

Mike brings over 30 years of international experience in the aerospace aftermarket materials services sector. With a proven track record from senior leadership roles at Airbus and, most recently, Satair, Mike possesses the expertise that will drive DASI, LLC’s future progress and innovation. With a deep understanding of the challenges and opportunities in the aftermarket, Mike is uniquely positioned to lead DASI through its next phase of growth.

DASI is committed to strengthening its position in the market, capitalizing on its relationship with equity partner Marubeni Corporation and increased finance capacity. Under Mike’s leadership, the company is poised for continued success.

About DASI 

DASI is the industry’s most efficient spot market. By connecting demand with spares supply of all types from sources around the globe.

With increasing pressure for “just in time” inventory, all industry end-users need a single reliable source for as many of their parts requirements as possible. DASI connects high quality, cost saving new surplus and USM with factory new parts from its OEM and distributor partners, giving equal access to all market players.

About Marubeni Corporation

Marubeni Corporation is a global trading and investment conglomerate headquartered in Tokyo, Japan. Founded in 1858, Marubeni operates in a wide range of industries, including energy, infrastructure, transportation, and agribusiness. The company has a strong track record of investing in innovative companies with high growth potential.

Mike Heaton, New President of DASI, LLC
Mike Heaton, New President of DASI, LLC

Delta Force Reveals Big Plans for 2025 Updates

New Release Windows for Mobile Version Announced

Los Angeles, Jan. 13, 2025 /PRNewswire/ — Today, Delta Force developer Team Jade revealed their plans for continuing content updates coming to the game in 2025, as well as gave an update on the release of the mobile version of Delta Force.

Delta Force has a bold plan for bringing its players fresh new content in 2025, including five new operators, seven new maps, new gadgets, new vehicles and more. For a full breakdown, please check out the Delta Force 2025 roadmap.

Team Jade will be sharing more when these seasons are dropping in the game soon, in the meantime, please visit the game’s official website for more information about Delta Force.

Team Jade also provided an update on the release window for the much anticipated mobile version of the game. In a message to Delta Force Players by Game Director Shadow Guo, the team is committed to delivering the top tier experience that players deserve, and to do that means moving the release of the mobile version to the Summer of 2025.

For more information about Delta Force visit our official website and YouTube channel, with additional updates found on X, Facebook, Instagram, and TikTok.

About Delta Force

Delta Force is the well-received free-to-play tactical shooter, serving as the next installment of the beloved Delta Force series. Featuring large-scale multiplayer modes, as well as an action-packed single-player/co-op campaign, a deep weapons arsenal for customization, and more, Delta Force can now be downloaded for free via its website, Delta Force on Steam and Epic Games Store pages.

About Team Jade

Team Jade is a notable branch of TiMi Studio Group renowned for Call of Duty: Mobile and Assault Fire, the latter being the most popular Chinese shooter game on PC for the past decade. With a roster of hundreds of industry veterans, the team has garnered multiple prestigious accolades, including BAFTA and TGA awards.

BingX Expands DeFi Access with Exclusive Launchpad for SOLV Token

PANAMA CITY, Jan. 13, 2025 /PRNewswire/ — BingX, a global leading cryptocurrency exchange, has announced the launch of SOLV token from Solv Protocol on BingX Launchpad. The subscription for the SOLV token will officially open on January 16, 2025, and the token will be listed on the BingX spot market at 18:00 (GMT+8) on January 17, 2025.

BingX Expands DeFi Access with Exclusive Launchpad for SOLV Token
BingX Expands DeFi Access with Exclusive Launchpad for SOLV Token

Solv Protocol is a decentralized finance (DeFi) platform designed to unlock the liquidity of Bitcoin and other digital assets within the DeFi ecosystem. It has quickly gained prominence in the cryptocurrency space by offering innovative solutions that enhance the utility of Bitcoin and other crypto assets. As the exclusive launchpad for SOLV, BingX offers unique access to participate in SOLV token distribution and trading. It allows BingX users to explore varied yield opportunities without sacrificing liquidity, enabling easy integration of Bitcoin into the DeFi ecosystem.

The total subscription pool for the Solv Protocol Launchpad is 4 million SOLV tokens. All BingX users are eligible to participate in the subscription, with each user guaranteed a successful subscription. The final individual subscription quota is directly proportional to the average amount of assets held by the user between January 13th and January 16th, based on asset snapshots. The individual winning limit is set at 20,000 SOLV tokens. Meanwhile, users can increase this limit by inviting friends to join. For each successful referral, both the user and their invited friend will benefit from an enhanced limit.

As part of the rewards program, BingX users can also participate in the exclusive “Learn to Earn” SOLV campaign. BingX users can complete Solv Protocol quizzes, make SOLV deposits, trade SOLV, and invite friends to earn a share of the 500,000 SOLV prize pool. New users who sign up on BingX are also eligible to receive airdrops. Furthermore, one lucky participant will win a lottery and receive a 20,000 SOLV airdrop.

“We are excited to launch the SOLV token on BingX Launchpad, marking a significant milestone in empowering our users with unparalleled access to innovative DeFi solutions.” Vivien Lin, Chief Product Officer at BingX, commented: “At BingX, we are committed to offering opportunities for our community to engage with groundbreaking blockchain projects. Through BingX Launchpad, we hope to shine a light on promising projects and help bring game-changing innovations to a global audience.”

BingX Launchpad is a cutting-edge platform faciliating the launch of early-stage crypto projects. It offers structured token distribution, global audience engagement, and rapid growth. By leveraging BingX’s expertise and network, it ensures projects reach the market efficiently.

About BingX
Founded in 2018, BingX is a leading crypto exchange, serving over 10 million users worldwide. BingX offers diversified products and services, including spot, derivatives, copy trading, and asset management – all designed for the evolving needs of users, from beginners to professionals. BingX is committed to providing a trustworthy platform that empowers users with innovative tools and features to elevate their trading proficiency. In 2024, BingX proudly became the official crypto exchange partner of Chelsea Football Club, marking an exciting debut in the world of sports.

For more information please visit: https://bingx.com/

Luzerne’s Craftsmanship Helps Dehua Ceramic Trade Association (China) Secure Guinness World Records Title for Largest Porcelain Car Sculpture (supported)

SINGAPORE, Jan. 13, 2025 /PRNewswire/ — Luzerne Pte Ltd is proud to announce its crucial role in helping the Dehua Ceramic Trade Association (China) secure the GUINNESS WORLD RECORDS™ title for producing the largest porcelain sculpture of a car (supported). Guinness World Records is the global authority on record-breaking achievements, with strict criteria for titles, including measurability, standardisation, verifiability, and the requirement to be the best in the world.

Selina Tang, CEO, with Luzerne staff celebrating the Guinness World Records™ title for the Largest Porcelain Car Sculpture (Supported), achieved in collaboration with the Dehua Ceramic Trade Association (China).
Selina Tang, CEO, with Luzerne staff celebrating the Guinness World Records™ title for the Largest Porcelain Car Sculpture (Supported), achieved in collaboration with the Dehua Ceramic Trade Association (China).

On 14 August 2024, Luzerne’s craftsmanship officially broke the record for producing the world’s first car model fully sculpted in porcelain on a scale of 1:1 and weighing in at an impressive 1.4 tonnes. According to officials from Guinness World Records, onsite measurements of the car show a body length of 5.51 metres, a width of 2.15 metres and a height of 1.39 metres, giving a combined measurement of 9.05 metres. This exceeds the minimum requirement of 8 metres for an entry in this category, thereby being listed officially in the Guinness World Records Hall of Fame.

In collaboration with the Dehua Ceramic Trade Association in China, Luzerne Pte Ltd spent 11 months accomplishing this feat in its wholly-owned factory situated in the county. Dehua, Fujian province, China, is the birthplace of Blanc de Chine, a name given to porcelain celebrated for its soft ivory-white hue, which is also manifested on the car’s exterior. In 2021, the kilns of Dehua were inscribed on the UNESCO World Heritage List. The Chinese government had also conferred it the honour of the National Civilised City Award (NCCA) to boost its development and status as the World’s Porcelain City.

The feat is also a significant testament to the craftsmanship of the 50 craftsmen who worked on the project. The sheer size of the sculpture and its complicated form have thus added to the difficulty of this challenge. “The team of 50 boasts diverse skillsets, so we benefited greatly from teamwork to accomplish this feat; it is impossible to do it alone. Dehua is the world’s porcelain city and we have a mission to spread its name afar,” explained Mr Peter Lek, Managing Director of Hiap Huat Holdings Pte Ltd and Chairman of Luzerne Pte Ltd.

The Dehua county government also elaborated that it will continue exploring new inroads in ceramic culture and art, breaking frontiers in its global recognition and raising market competitiveness. This is in its overall vision of using Blanc de Chine as a conversation intermediary with the rest of the world.

About Luzerne

Luzerne has been designing and producing bespoke quality tableware for some of the world’s most renowned restaurants, hotels and chefs since 2004. We pioneered the creation of fine china without animal bone ash, and the Luzerne factory in Dehua is the first in the world to be Halal-certified. We are also humbled to be named the Century Best Brand in China in 2019.

Drawing on over 75 years of expertise, we became Singapore’s first tableware manufacturer to develop its own line of products and produces up to 28 million pieces of ceramic and stone tableware annually at our fully-automated factory in Dehua. Our strategic location in Dehua, China comes as no surprise for the charming county is historically the birthplace of Blanc de Chine Dehua also holds several accolades such as The World Porcelain City and The National Civilised City Award conferred by the Chinese government. In 2021, its kilns were ceremoniously inscribed on the UNESCO World Heritage List.

Luzerne’s global presence in over 60 countries is supported by 800 employees in 5 offices in China (Shanghai, Xiamen, Dehua), Cambodia, and our headquarters in Singapore. Luzerne tableware is used in restaurants and hotels globally, and can also be experienced in the skies with Singapore Airlines. It is the preferred brand with renowned hospitality chains.

For more information, please visit www.luzerne.com.

About Guinness World Records

Guinness World Records™ is the global authority on record-breaking achievements. Established in 1955, the organisation has become synonymous with documenting extraordinary feats, unique talents, and remarkable accomplishments across the world. With a mission to celebrate the best in human endeavour and to inspire people of all ages, cultures, and nationalities, Guinness World Records™ continues to push the boundaries of what is possible.

Each year, millions of people attempt to break records, and only the most extraordinary are awarded the official Guinness World Records™ title. From awe-inspiring human achievements to groundbreaking technological advancements, Guinness World Records™ recognises and honours the incredible potential of individuals, teams, and organisations worldwide.

For more information, please visit www.guinnessworldrecords.com.

Gianna Lullume Baby Soother Device Officially Launches on Kickstarter

HONG KONG, Jan. 13, 2025 /PRNewswire/ — Gianna Lullume, an innovative brand committed to improving infant sleep and promoting family well-being, is proud to announce the official launch of its crowdfunding campaign on Kickstarter. Designed for infants and toddlers aged 0-4, the Gianna Lullume Baby Soother Device offers a cutting-edge solution to one of parenting’s most significant challenges: sleepless nights.

Gianna Lullume Baby Soother Device
Gianna Lullume Baby Soother Device

https://www.kickstarter.com/projects/giannalullumesoother/gianna-baby-soother-with-cry-detection

This advanced sleep device integrates cry detection technology, sound therapy, and red-light therapy to create a soothing, smart sleep environment. The result? Better sleep for babies and peace of mind for parents.

Key Features:

  • Cry Detection Technology: Detects a baby’s cry within 20 seconds and automatically responds with calming sounds and lights to soothe the baby before their distress escalates.
  • Red Light Therapy: Scientifically designed red light promotes melatonin production, supporting natural sleep cycles without disrupting the baby’s rest.
  • Sound Therapy: Offers a variety of soothing options, including white noise, pink noise, nature sounds, and womb-like heartbeats, all optimized for infant relaxation and safety.
  • Smart App Control: Enables parents to remotely manage settings, timers, and notifications, ensuring convenience and customization.

“At Gianna Lullume, we believe that a better sleep for babies translates to a better sleep for the entire family,” said Simon Shawn, CEO of Gianna. “Our mission is to equip parents with intelligent tools that bring comfort to their little ones while fostering a calm and restful home environment.”

Join the Movement

The Kickstarter campaign is now live, offering exclusive early-bird rewards for backers who choose to join the mission to redefine sleep for families worldwide. Supporters can visit the campaign page at Kickstarter to learn more about the product and secure special launch perks.

About Gianna Lullume

Founded with the vision of improving the lives of families through science-backed sleep solutions, Gianna Lullume specializes in innovative devices designed to support infants and toddlers. By combining thoughtful design, advanced technology, and a deep understanding of parental needs, Gianna Lullume aims to make restful nights a reality for families everywhere.

Sleepless or Restless?Soothing Your Little One with Gianna Lullume.

For media inquiries, please contact:
market@giannashop.com

Gianna Branding Team
brand@kerchangroup.com 

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

SHANGHAI and NORTH CHICAGO, Ill., Jan. 13, 2025 /PRNewswire/ — Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement to develop SIM0500, an investigational new drug candidate. SIM0500 is currently in Phase 1 clinical trials in patients with relapsed or refractory multiple myeloma (MM), in both China and the U.S.

Cooperation of Simcere Zaiming and Abbvie
Cooperation of Simcere Zaiming and Abbvie

SIM0500 is a humanized trispecific antibody that targets GPRC5D, BCMA, and CD3, developed independently by Simcere Zaiming using their T-cell engager polyspecific antibody technology platform. This molecule features a low affinity/high target-activating CD3 engaging arm and binding sites for the two tumor antigens: G-Protein-coupled receptor class 5 member D (GPRC5D) and B-cell maturation antigen (BCMA). SIM0500 has shown strong T cell cytotoxicity against multiple myeloma (MM) cells by leveraging a combination of various antitumor effects.

“As a leader in hematologic malignancies, AbbVie is committed to advancing innovative treatments for complex cancers like multiple myeloma through our relentless R&D efforts and collaborations,” said Mariana Cota Stirner, M.D., Ph.D., vice president, therapeutic area head for hematology, AbbVie. “We look forward to partnering with Simcere Zaiming, to advance this novel trispecific antibody, which has the potential to help address significant unmet medical needs for people living with multiple myeloma”

“SIM0500 is developed via Simcere Zaiming’s proprietary T-cell engager platform,” said Renhong Tang, PhD, CEO of Simcere Zaiming. “We are excited to partner with AbbVie on this novel drug candidate and look forward to working together to advance the clinical development of SIM0500. ”

Simcere Zaiming will receive an upfront payment from AbbVie and is eligible to receive option fees and milestone payments of up to $1.055B, as well as tiered royalties on net sales outside of the Greater China territory. AbbVie is eligible to receive tiered royalties on net sales in the Greater China territory

About AbbVie in Oncology

At AbbVie, we are committed to transforming standards of care for patients living with difficult-to-treat cancers. We are advancing a dynamic pipeline of investigational therapies across a range of cancer types in both blood cancers and solid tumors. We are focusing on creating targeted medicines that either impede the reproduction of cancer cells or enable their elimination. We achieve this through various, targeted treatment modalities and biology interventions, including small molecule therapeutics, antibody-drug conjugates (ADCs), immuno-oncology-based therapeutics, multispecific antibody and in situ CAR-T platforms. Our dedicated and experienced team joins forces with innovative partners to accelerate the delivery of potential breakthrough medicines.

Today, our expansive oncology portfolio comprises approved and investigational treatments for a wide range of blood and solid tumors. We are evaluating more than 20 investigational medicines in multiple clinical trials across some of the world’s most widespread and debilitating cancers. As we work to have a remarkable impact on people’s lives, we are committed to exploring solutions to help patients obtain access to our cancer medicines. For more information, please visit http://www.abbvie.com/oncology.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. AbbVie strives to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in AbbVie’s Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

About Simcere Zaiming

Simcere Zaiming is an oncology-focused biopharmaceutical company and a subsidiary of Simcere Pharmaceutical Group Limited (HKEX: 2096, “Simcere”). Founded in 2023, Simcere Zaiming dedicated to developing groundbreaking therapies to meet the unmet clinical needs of cancer patients globally. With a robust and innovative R&D pipeline featuring distinct clinical assets, Simcere Zaiming has successfully launched several innovative products in China, including COSELA®, Enweida®, Endostar®, and Enlituo®. The company is determined to deliver potentially transformative treatment options to cancer patients worldwide through its internal R&D, manufacturing, and commercialization capabilities, complemented by strategic collaborations with leading partners.

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS’ LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism.

DUBLIN, Calif. and JENA, Germany, Jan. 13, 2025 /PRNewswire/ — ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia and mixed astigmatism (a condition where both hyperopic and myopic correction is required). The ZEISS MEL 90 fully integrates into the Corneal Refractive Workflow to offer U.S. surgeons a fast, reliable, and streamlined surgery experience, complementing the VISUMAX® 800 with SMILE® pro from ZEISS to help further broaden a surgeon’s refractive business with improved patient attraction and positive clinical outcomes.

ZEISS MEL 90 Excimer Laser
ZEISS MEL 90 Excimer Laser

“The increasing global adoption of laser vision correction reflects the advancements and positive impact the technology continues to have on the quality of life for patients,” says Magnus Reibenspiess, Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology. “With the integration of the ZEISS MEL 90, surgeons can confidently care for their patients with greater workflow efficiency and performance with enhanced outcomes.”

“ZEISS continues to break new ground as a leader in the LVC market, reflecting our ongoing commitment to and support of U.S. surgeons and patients with the latest refractive innovation that helps set practices apart and provides more options to more patients,” says Andrew Chang, Head of Global Sales for ZEISS Medical Technology. “With the availability of the ZEISS MEL 90 in the U.S. market, surgeons can now offer an integrated workflow of refractive technology to help reach new patients and provide excellent outcomes for them.”

“The FDA approval of the ZEISS MEL 90 excimer laser is a game changer for refractive surgery in the U.S. This advanced technology, with its Triple-A ablation algorithm and fast ablation speed, sets a new benchmark for precision, safety, and efficiency. I am particularly impressed by the system’s ability to simplify treatment planning while delivering highly predictable and tissue-conserving results. The integration of the ZEISS MEL 90 with the ZEISS VISUMAX 800 femtosecond laser opens new doors for streamlined workflows and optimal patient outcomes. This approval marks an exciting chapter for surgeons and patients alike,” says Dr. John Doane, Refractive Surgeon, Discover Vision Centers, Kansas City, MO.

Reliable Outcomes: The ZEISS MEL 90 offers Triple-A (Advanced Ablation Algorithm), which is a single ablation profile for a wide range of sphero-cylindrical (SCA) corrections that simplifies treatment planning. Triple-A offers a high degree of accuracy, reproducibility and predictability, as well as advantages such as tissue-saving ablation. Its preinstalled functions also offer surgeons optimal support for achieving excellent treatment results and gentle treatments of standard, higher and lower levels of ametropia and astigmatism.

Fast Ablation Speed: The ZEISS MEL 90 offers a truly customized power package. When performing LASIK for myopia at 500 Hz, the ZEISS MEL 90 can intra-operatively ablate 1 diopter in as little as 1.3 seconds.1 Intuitive system guidance and speedy treatment planning allow for additional time savings. The ZEISS MEL 90 excimer laser technology is equipped with an active eye tracker which delivers an excellent response time, providing a high level of treatment safety with very stable results.

Easy to Use: New capabilities of the ZEISS MEL 90 excimer laser greatly simplify the interactions between the surgeon, the assisting staff and the system technology. The excimer laser can be configured to precisely match the surgeon and the OR team’s needs. The system’s simple, intuitive graphic user interface supports fast treatment procedures, and the touch screen can be flexibly positioned wherever it is needed to enable the surgeon to have good ergonomic sitting posture throughout an operation. A second, optional touch screen can be configured to optimally complement the treatment routine of the OR team. An HD video port, network printer connection, and PDF export capabilities offer additional workflow support.

With the ZEISS MEL 90, the company expands its offerings for U.S. refractive clinics and helps support the improvement of clinical outcomes and patient satisfaction through onboarding, training, service support and ZEISS Practice Development Consulting.

The ZEISS MEL 90 excimer laser is currently available in the U.S. For more information, visit www.zeiss.com/us/mel-90

1LASIK myopia, optical zone 6 mm.

Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals’ content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.

Brief profile

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For more information visit our website at www.zeiss.com/med